How to Finance a Hospice Agency Acquisition

From SBA 7(a) loans to seller notes, understand the capital stack options for acquiring a Medicare-certified hospice business in the $1M–$5M revenue range.

Find Hospice & Palliative Care Deals SBA Calculator →

Acquiring a hospice agency involves unique financing considerations — Medicare certification continuity, compliance escrow holdbacks, and census-dependent cash flow all shape how lenders and sellers structure deals. Most lower middle market hospice acquisitions combine SBA debt, conventional healthcare lending, or seller financing to bridge valuation gaps and manage regulatory transition risk during the Medicare change-of-ownership process.

Financing Options for Hospice & Palliative Care Acquisitions

SBA 7(a) Loan

$500K–$5MPrime + 2.75%–3.75% (variable); currently ~10%–11.5%

The most accessible path for individual buyers acquiring Medicare-certified hospice agencies. SBA 7(a) loans cover goodwill, licensing, and working capital needs, making them well-suited for asset purchases with provider agreement novation.

Pros

Low down payment requirement (typically 10%) preserves buyer working capital for post-close operational needs
Goodwill and intangible assets including Medicare certification value are eligible collateral
Seller notes up to 10% of purchase price can count toward equity injection under SBA guidelines

Cons

×Lenders scrutinize Medicare cap exposure and billing compliance history, which can delay or derail approval
×Change-of-ownership timeline with CMS can complicate SBA loan closing schedules and draw periods
×Personal guarantee required; buyers with limited healthcare operating history may face additional underwriting scrutiny

Conventional Healthcare Lending

$1M–$10M+7%–10% fixed or floating depending on lender and borrower profile

Regional banks and specialty healthcare lenders offer term loans and credit facilities to experienced hospice operators or PE-backed platforms with existing cash flow and collateral, often structured around EBITDA-based covenants.

Pros

Faster closing timelines compared to SBA; preferred by PE-backed roll-up platforms on multiple acquisitions
More flexibility in deal structure including earnouts, equity rollovers, and compliance holdback provisions
Larger loan sizes available for acquirers with demonstrated hospice operational track records and ADC history

Cons

×Requires stronger borrower financials and often 20%–30% equity contribution versus SBA's 10%
×Lenders impose strict covenants tied to ADC, payer mix, and DSCR that can restrict operational flexibility post-close
×Less accessible for first-time buyers without an established healthcare portfolio or institutional backing

Seller Financing / Seller Note

10%–20% of purchase price; typically $150K–$800K6%–8% fixed; interest-only periods common during Medicare transition window

Founder-operated hospice sellers often carry 10–20% of the purchase price as a subordinated note, helping bridge valuation gaps, demonstrate seller confidence in business continuity, and smooth Medicare CHOW transition risk for lenders.

Pros

Aligns seller incentives with post-close census retention and staff continuity critical to hospice cash flow
Reduces buyer cash required at close and satisfies SBA equity injection requirements when structured correctly
Signals seller confidence to lenders and improves overall deal bankability with Medicare compliance escrow provisions

Cons

×Sellers may resist notes if concerned about personal Medicare billing liability surfacing post-close
×Subordinated position behind SBA or senior lender limits seller recourse if buyer defaults post-transition
×Note terms can become contentious if earnout or census retention milestones are tied to post-close performance

Sample Capital Stack

$2,800,000 (hospice agency; $1.8M revenue; $500K EBITDA; 5.6x multiple)

Purchase Price

~$22,500/month combined debt service on SBA loan and seller note at blended ~10.5% over 10 years

Monthly Service

~1.85x based on $500K EBITDA after normalized owner compensation; comfortably above typical 1.25x lender minimum

DSCR

SBA 7(a) Loan: $2,240,000 (80%) | Seller Note: $280,000 (10%) | Buyer Equity: $280,000 (10%)

Model your own deal structure →

Lender Tips for Hospice & Palliative Care Acquisitions

1Present a clean 3-year Medicare cost report history and current cap position calculation upfront — lenders underwriting hospice deals treat unresolved cap exposure as a direct liability against EBITDA.
2Document ADC trends, payer mix, and live discharge rates in your loan package; these metrics validate revenue stability and demonstrate clinical quality to healthcare-specialized lenders.
3Use a healthcare M&A attorney experienced in Medicare CHOW to build a closing timeline that aligns SBA loan funding with CMS provider agreement novation — misaligned timelines are a common deal killer.
4Structure a compliance escrow holdback of 5%–10% of purchase price within the deal to satisfy lender concerns about undisclosed RAC audit findings or Medicare overpayment recoupment risk post-close.

Frequently Asked Questions

Can I use an SBA loan to buy a Medicare-certified hospice agency?

Yes. Hospice acquisitions are SBA 7(a) eligible. Lenders focus heavily on Medicare billing compliance history, cap position, and ADC stability as underwriting criteria alongside standard business financials.

How does the Medicare change-of-ownership process affect financing timelines?

CMS CHOW approval can take 30–90 days post-close. SBA lenders need to coordinate funding timing carefully; some deals use interim operating agreements to bridge the gap without disrupting Medicare billing.

What DSCR do hospice acquisition lenders typically require?

Most lenders require a minimum 1.25x DSCR on normalized EBITDA. Hospice-specific lenders also stress-test against a 5%–10% census decline scenario given the reimbursement volatility inherent in Medicare-dependent revenue.

Will undisclosed Medicare audit exposure affect my ability to get financing?

Yes significantly. Active RAC audits or unresolved overpayment demands can cause lenders to reduce loan amounts, require larger escrow holdbacks, or decline financing entirely until compliance risk is quantified and indemnified.

More Hospice & Palliative Care Guides

Buy a Hospice & Palliative Care Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Hospice & Palliative Care acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required